Format
Sort by
Items per page

Send to

Choose Destination

See Gene information for abca1 apoa1

abca1 in Homo sapiens (2)Mus musculus (2)Rattus norvegicus (2)All 245 Gene records

apoa1 in Homo sapiens (2)Mus musculus (2)Rattus norvegicus (2)All 190 Gene records

Search results

Items: 1 to 20 of 211

1.

The biochemical and genetic diagnosis of lipid disorders.

Schaefer EJ, Geller AS, Endress G.

Curr Opin Lipidol. 2019 Apr;30(2):56-62. doi: 10.1097/MOL.0000000000000590.

PMID:
30720493
2.

Relation of High-Density Lipoprotein Charge Heterogeneity, Cholesterol Efflux Capacity, and the Expression of High-Density Lipoprotein-Related Genes in Mononuclear Cells to the HDL-Cholesterol Level.

Dergunov AD, Litvinov DY, Bazaeva EV, Dmitrieva VG, Nosova EV, Rozhkova AV, Dergunova LV.

Lipids. 2018 Oct;53(10):979-991. doi: 10.1002/lipd.12104. Epub 2018 Nov 15.

PMID:
30430582
3.

V-ATPase (Vacuolar ATPase) Activity Required for ABCA1 (ATP-Binding Cassette Protein A1)-Mediated Cholesterol Efflux.

Lorkowski SW, Brubaker G, Gulshan K, Smith JD.

Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2615-2625. doi: 10.1161/ATVBAHA.118.311814.

PMID:
30354238
4.

Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.

Geller AS, Polisecki EY, Diffenderfer MR, Asztalos BF, Karathanasis SK, Hegele RA, Schaefer EJ.

J Lipid Res. 2018 Dec;59(12):2421-2435. doi: 10.1194/jlr.M088203. Epub 2018 Oct 17.

PMID:
30333156
5.

ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone.

Aguirre-Portolés C, Feliu J, Reglero G, Ramírez de Molina A.

Mol Oncol. 2018 Oct;12(10):1735-1752. doi: 10.1002/1878-0261.12367. Epub 2018 Sep 17.

6.

Novel Insights into Concepts and Directionality of Maternal⁻Fetal Cholesterol Transfer across the Human Placenta.

Kallol S, Huang X, Müller S, Ontsouka CE, Albrecht C.

Int J Mol Sci. 2018 Aug 9;19(8). pii: E2334. doi: 10.3390/ijms19082334.

7.

Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within.

Kajani S, Curley S, McGillicuddy FC.

Int J Mol Sci. 2018 Jul 6;19(7). pii: E1971. doi: 10.3390/ijms19071971. Review.

8.

Lipid reducing activity of novel cholic acid (CA) analogs: Design, synthesis and preliminary mechanism study.

Luo G, Qian Z, Qiu R, You Q, Xiang H.

Bioorg Chem. 2018 Oct;80:396-407. doi: 10.1016/j.bioorg.2018.07.002. Epub 2018 Jul 5.

PMID:
29986186
9.

Large-scale deletions of the ABCA1 gene in patients with hypoalphalipoproteinemia.

Dron JS, Wang J, Berberich AJ, Iacocca MA, Cao H, Yang P, Knoll J, Tremblay K, Brisson D, Netzer C, Gouni-Berthold I, Gaudet D, Hegele RA.

J Lipid Res. 2018 Aug;59(8):1529-1535. doi: 10.1194/jlr.P086280. Epub 2018 Jun 4.

10.

Interactions among genes involved in reverse cholesterol transport and in the response to environmental factors in dyslipidemia in subjects from the Xinjiang rural area.

Wang X, Guo H, Li Y, Wang H, He J, Mu L, Hu Y, Ma J, Yan Y, Li S, Ding Y, Zhang M, Niu Q, Liu J, Zhang J, Ma R, Guo S.

PLoS One. 2018 May 14;13(5):e0196042. doi: 10.1371/journal.pone.0196042. eCollection 2018.

11.

Effects of Rosuvastatin on the expression of the genes involved in cholesterol metabolism in rats: adaptive responses by extrahepatic tissues.

Ahmadi Y, Haghjoo AG, Dastmalchi S, Nemati M, Bargahi N.

Gene. 2018 Jun 30;661:45-50. doi: 10.1016/j.gene.2018.03.092. Epub 2018 Mar 29.

PMID:
29605604
12.

Interleukin-32 upregulates the expression of ABCA1 and ABCG1 resulting in reduced intracellular lipid concentrations in primary human hepatocytes.

Damen MSMA, Dos Santos JC, Hermsen R, Adam van der Vliet J, Netea MG, Riksen NP, Dinarello CA, Joosten LAB, Heinhuis B.

Atherosclerosis. 2018 Apr;271:193-202. doi: 10.1016/j.atherosclerosis.2018.02.027. Epub 2018 Mar 2.

13.

GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr-/- mice.

Silva JC, de Oliveira EM, Turato WM, Trossini GHG, Maltarollo VG, Pitta MGR, Pitta IR, de Las Heras B, Boscá L, Rudnicki M, Abdalla DSP.

Int J Obes (Lond). 2018 Jun;42(5):1062-1072. doi: 10.1038/s41366-018-0011-7. Epub 2018 Jan 30.

PMID:
29453462
14.

Effects of Increasing Exercise Intensity and Dose on Multiple Measures of HDL (High-Density Lipoprotein) Function.

Sarzynski MA, Ruiz-Ramie JJ, Barber JL, Slentz CA, Apolzan JW, McGarrah RW, Harris MN, Church TS, Borja MS, He Y, Oda MN, Martin CK, Kraus WE, Rohatgi A.

Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):943-952. doi: 10.1161/ATVBAHA.117.310307. Epub 2018 Feb 8. Erratum in: Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):e136.

15.

From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease.

Sacks FM, Jensen MK.

Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):487-499. doi: 10.1161/ATVBAHA.117.307025. Epub 2018 Jan 25. Review.

16.

microRNA-212 promotes lipid accumulation and attenuates cholesterol efflux in THP-1 human macrophages by targeting SIRT1.

Miao H, Zeng H, Gong H.

Gene. 2018 Feb 15;643:55-60. doi: 10.1016/j.gene.2017.11.058. Epub 2017 Nov 23.

PMID:
29174964
17.

Changes in High-Density Lipoprotein Cholesterol Efflux Capacity After Bariatric Surgery Are Procedure Dependent.

Heffron SP, Lin BX, Parikh M, Scolaro B, Adelman SJ, Collins HL, Berger JS, Fisher EA.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):245-254. doi: 10.1161/ATVBAHA.117.310102. Epub 2017 Nov 21.

18.

Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1.

Abdel-Razek O, Sadananda SN, Li X, Cermakova L, Frohlich J, Brunham LR.

J Clin Lipidol. 2018 Jan - Feb;12(1):116-121. doi: 10.1016/j.jacl.2017.10.010. Epub 2017 Nov 10.

PMID:
29150341
19.

ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate.

Xu B, Gillard BK, Gotto AM Jr, Rosales C, Pownall HJ.

Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2260-2270. doi: 10.1161/ATVBAHA.117.310290. Epub 2017 Oct 26.

20.

Citrobacter rodentium Subverts ATP Flux and Cholesterol Homeostasis in Intestinal Epithelial Cells In Vivo.

Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Carson D, Pevsner-Fischer M, Furniss RCD, Dougan G, Dori-Bachash M, Yu L, Clements A, Collins JW, Elinav E, Larrouy-Maumus GJ, Choudhary JS, Frankel G.

Cell Metab. 2017 Nov 7;26(5):738-752.e6. doi: 10.1016/j.cmet.2017.09.003. Epub 2017 Oct 5.

Supplemental Content

Loading ...
Support Center